Objective: Coronavirus disease 2019 is a heterogeneous disease most frequently causing respiratory tract infection, which can induce respiratory failure and multiple organ …
J Hazeldine, JM Lord - Frontiers in immunology, 2021 - frontiersin.org
Whilst the majority of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of COVID-19, experience mild to …
K Bartoszewicz, M Bartoszewicz… - Journal of Medical …, 2024 - microbiologyresearch.org
Introduction. The Coronavirus Disease 2019 (COVID-19) pandemic has had a significant impact on global healthcare, with high mortality and severe complications remaining a major …
Patients hospitalized in the intensive care unit (ICU) due to the COVID-19 experience a high incidence (up to 43%) of venous thromboembolic events. While laboratory findings in COVID …
J Sysiak-Sławecka, O Wichowska… - Anaesthesiology …, 2023 - termedia.pl
Results: We did not find a difference in the number of superinfections between the ECMO and CON groups (11 vs. 10, P= 1.0). The mortality rate was 67% in the ECMO group and …
JNV Santos, VA Mendonca, AC Fernandes… - International Journal of …, 2022 - mdpi.com
Introduction: COVID-19 is a public health emergency all around the world. Severe illness occurred in about 14% of patients and 5% of patients developed critical illness, but the …
M Mikiewicz, K Polok, P Somionka, J Krzywoń… - Anaesthesiology …, 2022 - termedia.pl
Results We enrolled 108 patients at a mean age of 64.3 (SD= 12) years, the majority of whom were male (63.9%). Mortality in the ICU, after 30 days and 90 days was …
JK Danel, M Taborek, A Nowotarska… - Anaesthesiology …, 2024 - termedia.pl
Results: Evaluation of nutritional therapy was performed in 129 subjects. The fulfilment of caloric requirement considering the HB, MsJ and ESPEN formula was 66%, 66.7% and …
Patients hospitalized in the intensive care unit (ICU) due to the COVID-19 experience a high incidence (up to 43%) of venous thromboembolic events. While laboratory findings in COVID …